A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants

NCT05252520 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The development of bermekimab in Immunology is stopped

Conditions

Healthy

Interventions

DRUG: JNJ-77474462

Sponsor

Janssen Research & Development, LLC